Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP55: High diagnostic accuracy of 4-probe methylation biomarkers in paediatric Inflammatory Bowel Disease by epigenome-wide analysisECCO'24 Stockholm
Year: 2024
Authors: Noble, Alexandra
DOP56: Fibrosis-related transcriptome unveils a distinctive matrix remodelling pattern in penetrating but not in stricturing ileal Crohn's DiseaseECCO'24 Stockholm
Year: 2024
Authors: Tavares de Sousa, Helena
DOP57: Cystic fibrosis risk variants confer a protective effect against Inflammatory Bowel Disease in large-scale exome sequencing analysisECCO'24 Stockholm
Year: 2024
Authors: Sazonovs, Aleksejs
DOP58: Human Leukocyte Antigen drives methylation signatures in primary sclerosing cholangitis but not in IgG4-related sclerosing cholangitis.ECCO'24 Stockholm
Year: 2024
Authors: Motta, Rodrigo
DOP59: Integration of in silico analysis and in vitro functional analysis reveals Tissue Factor Pathway Inhibitor 2 (TFPI2) as a master transcriptional regulator and potential target to impede Infliximab resistance in adult UC patientsECCO'24 Stockholm
Year: 2024
Authors: Genua, Flavia
DOP60: Prevalence of undiagnosed inflammatory Bowel Disease in patients with spondyloarthritis: EISER StudyECCO'24 Stockholm
Year: 2024
Authors: Gutiérrez Casbas, Ana
DOP61: Up-regulated Gremlin 1 in fibroblasts from Crohn’s Disease fibrotic strictures: A potential therapeutic targetECCO'24 Stockholm
Year: 2024
Authors: Santacroce, Giovanni
DOP62: A core molecular resistome characterised by extracellular matrix dysregulation and neutrophil degranulation predicts resistance to multiple therapies in Ulcerative ColitisECCO'24 Stockholm
Year: 2024
Authors: Saifuddin, Aamir
DOP63: Mortality in Pediatric-onset Immune-Mediated Inflammatory Disease – A Nationwide Study.ECCO'24 Stockholm
Year: 2024
Authors: Jansson, Sabine
DOP64: Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn’s Disease: Post hoc results from the phase 3b SEQUENCE trialECCO'24 Stockholm
Year: 2024
Authors: Raine, Timothy
DOP65: Infliximab plus azathioprine and quick steroids discontinuation versus azathioprine plus steroids in patients with acute severe Ulcerative Colitis responding to intravenous steroids: a parallel, open-label randomized controlled trialECCO'24 Stockholm
Year: 2024
Authors: Amiot, Aurelien
DOP66: INSPIRE: Preliminary data from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn’s Disease and complex perianal fistulasECCO'24 Stockholm
Year: 2024
Authors: Fathallah, Nadia
DOP67: MB310: From Clinical FMT to a Phase 1 Study with a Defined, Orally Administered Live Bacterial Therapeutic for Mild Moderate Ulcerative ColitisECCO'24 Stockholm
Year: 2024
Authors: Carter, Ron
DOP68: Natural history of isolated Crohn's Disease perianal fistulaECCO'24 Stockholm
Year: 2024
Authors: Wong, Serre-Yu
DOP69: Longitudinal gut microbiome dynamics in relation to disease flares in Inflammatory Bowel Disease, pilot data from the IBD-Tracker studyECCO'24 Stockholm
Year: 2024
Authors: Gacesa, Ranko
DOP70: Prevalence and severity of bowel urgency in Crohn’s Disease: Results from the Communicating Needs and Features of IBD Experience (CONFIDE) SurveyECCO'24 Stockholm
Year: 2024
Authors: Dubinsky, Marla C
DOP71: Efficacy of once-daily, orally administered obefazimod in patients with moderately to severely active UC at weeks 8, 48, and 96 broken down by induction treatment doseECCO'24 Stockholm
Year: 2024
Authors: Sands, Bruce E
DOP72: Pregnancy for IBD-patients with an enterostomy is feasible but is associated with complicationsECCO'24 Stockholm
Year: 2024
Authors: Bouwknegt, Dianne G.
DOP73: Early biological use in a Belgian, prospective inception cohort of patients with Inflammatory Bowel Disease: the PANTHER cohortECCO'24 Stockholm
Year: 2024
Authors: Verstockt, Sare
DOP74: Short and long-term effectiveness and safety of ustekinumab in Ulcerative Colitis in real life: the ULISES studyECCO'24 Stockholm
Year: 2024
Authors: Chaparro, María